BCTX Stock: BriaCell Therapeutics Corp. Stock Price, Analysis & Insights
Get live bctx stock price $11.92, comprehensive BriaCell Therapeutics Corp. stock analysis, charts, news, and expert forecast. Real-time bctx stock data and investment insights.
Loading chart...
Company Overview
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Company Information
- CEO
- William V. Williams FCPA,
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 16
Contact Information
- Website
- https://www.briacell.com
- Address
- Bellevue Centre
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.96)
Business Model & Strategy
BriaCell Therapeutics Corp. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO William V. Williams FCPA,, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
BriaCell Therapeutics Corp. competes in the Biotechnology within the broader Healthcare. With 22.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, BriaCell Therapeutics Corp. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating BriaCell Therapeutics Corp. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BriaCell Therapeutics Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for BriaCell Therapeutics Corp.
- ⚠Investors should consider how BriaCell Therapeutics Corp. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
22.45M
P/E Ratio
-0.19
Beta
1.96
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 22.45M market capitalization
- Trading Volume: 103.35K shares traded today
- Price Range: 52-week range of $3.50 - $98.20
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCTX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 22.45M, the company represents a significant player in its market. The stock is currently trading at $11.92 with a positivedaily change of 19.17%.
The company's 16 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.19, beta of 1.96, and 52-week price range from $3.50 to $98.20when evaluating investment opportunities.
Why Invest in BriaCell Therapeutics Corp.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under William V. Williams FCPA,
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.